<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>PreveCeutical Medical Inc.</title><link>https://investorshangout.com/PreveCeutical-Medical-Inc-PRVCF-92370/</link><description><![CDATA[PreveCeutical Medical Inc. (PRVCF)]]></description><language>en-us</language><pubDate>Sat, 12 Sep 2026 03:48:56 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/PreveCeutical-Medical-Inc-PRVCF-92370/" rel="self" type="application/rss+xml"/><item><title>louied91: $PRVCF PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program &amp;</title><link>https://investorshangout.com/post/view?id=6550237</link><guid>https://investorshangout.com/post/view?id=6550237</guid><description><![CDATA[louied91
]]></description><pubDate>Mon, 20 Mar 2023 11:53:38 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Enters LOI t</title><link>https://investorshangout.com/post/view?id=5226784</link><guid>https://investorshangout.com/post/view?id=5226784</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 04 Oct 2018 21:31:51 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Partners with Asterion Cannabis </title><link>https://investorshangout.com/post/view?id=5225748</link><guid>https://investorshangout.com/post/view?id=5225748</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 03 Oct 2018 21:17:59 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Jo</title><link>https://investorshangout.com/post/view?id=5220324</link><guid>https://investorshangout.com/post/view?id=5220324</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 26 Sep 2018 23:01:35 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) “Gets It Right” in Cannabinoid E</title><link>https://investorshangout.com/post/view?id=5217873</link><guid>https://investorshangout.com/post/view?id=5217873</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 24 Sep 2018 22:01:48 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Strategicall</title><link>https://investorshangout.com/post/view?id=5215970</link><guid>https://investorshangout.com/post/view?id=5215970</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 21 Sep 2018 22:22:06 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Building on Key Milestones in So</title><link>https://investorshangout.com/post/view?id=5211198</link><guid>https://investorshangout.com/post/view?id=5211198</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 17 Sep 2018 21:24:55 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Advances Nat</title><link>https://investorshangout.com/post/view?id=5209198</link><guid>https://investorshangout.com/post/view?id=5209198</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 14 Sep 2018 21:45:45 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Deploys Winning R&amp;D Strategy</title><link>https://investorshangout.com/post/view?id=5201940</link><guid>https://investorshangout.com/post/view?id=5201940</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 06 Sep 2018 22:03:21 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Develops Pro</title><link>https://investorshangout.com/post/view?id=5199765</link><guid>https://investorshangout.com/post/view?id=5199765</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 04 Sep 2018 21:47:53 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Developmen</title><link>https://investorshangout.com/post/view?id=5197508</link><guid>https://investorshangout.com/post/view?id=5197508</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 31 Aug 2018 21:09:03 GMT</pubDate></item><item><title>NetworkNewsWire: Update Highlights PreveCeutical Medical’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Efforts to Establ</title><link>https://investorshangout.com/post/view?id=5195901</link><guid>https://investorshangout.com/post/view?id=5195901</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 30 Aug 2018 21:41:36 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Acquires Worldwide License for H</title><link>https://investorshangout.com/post/view?id=5185287</link><guid>https://investorshangout.com/post/view?id=5185287</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 22 Aug 2018 21:14:40 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Issues Share</title><link>https://investorshangout.com/post/view?id=5185248</link><guid>https://investorshangout.com/post/view?id=5185248</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 22 Aug 2018 20:48:39 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Medicinal Cannabis Division Ta</title><link>https://investorshangout.com/post/view?id=5176735</link><guid>https://investorshangout.com/post/view?id=5176735</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 16 Aug 2018 21:12:39 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Inks Licensi</title><link>https://investorshangout.com/post/view?id=5174974</link><guid>https://investorshangout.com/post/view?id=5174974</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 15 Aug 2018 20:58:02 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is Named for its Attention to Pr</title><link>https://investorshangout.com/post/view?id=5171706</link><guid>https://investorshangout.com/post/view?id=5171706</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 13 Aug 2018 22:01:43 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Unveils Medi</title><link>https://investorshangout.com/post/view?id=5166306</link><guid>https://investorshangout.com/post/view?id=5166306</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 08 Aug 2018 21:55:39 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Advances Controlled Synthesis of</title><link>https://investorshangout.com/post/view?id=5160723</link><guid>https://investorshangout.com/post/view?id=5160723</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 03 Aug 2018 23:55:55 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Posts Update</title><link>https://investorshangout.com/post/view?id=5155410</link><guid>https://investorshangout.com/post/view?id=5155410</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 31 Jul 2018 20:25:20 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Establishes Business Unit for $5</title><link>https://investorshangout.com/post/view?id=5152000</link><guid>https://investorshangout.com/post/view?id=5152000</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 27 Jul 2018 22:49:06 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Breakthrough Sol-gel Drug Delivery </title><link>https://investorshangout.com/post/view?id=5149088</link><guid>https://investorshangout.com/post/view?id=5149088</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 25 Jul 2018 23:14:12 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Launches Med</title><link>https://investorshangout.com/post/view?id=5147354</link><guid>https://investorshangout.com/post/view?id=5147354</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 24 Jul 2018 22:19:24 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) CEO Outlines Next Steps for Prom</title><link>https://investorshangout.com/post/view?id=5134309</link><guid>https://investorshangout.com/post/view?id=5134309</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 16 Jul 2018 20:25:38 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Delivers Gro</title><link>https://investorshangout.com/post/view?id=5134271</link><guid>https://investorshangout.com/post/view?id=5134271</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 16 Jul 2018 20:03:04 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Issues Updat</title><link>https://investorshangout.com/post/view?id=5127292</link><guid>https://investorshangout.com/post/view?id=5127292</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 11 Jul 2018 21:41:52 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Targets Chronic Disease, Prevent</title><link>https://investorshangout.com/post/view?id=5118125</link><guid>https://investorshangout.com/post/view?id=5118125</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 05 Jul 2018 23:44:45 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Conducts Ext</title><link>https://investorshangout.com/post/view?id=5118098</link><guid>https://investorshangout.com/post/view?id=5118098</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 05 Jul 2018 23:20:56 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Continues Advancing Innovative D</title><link>https://investorshangout.com/post/view?id=5115390</link><guid>https://investorshangout.com/post/view?id=5115390</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 03 Jul 2018 22:57:30 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Closes Overs</title><link>https://investorshangout.com/post/view?id=5110970</link><guid>https://investorshangout.com/post/view?id=5110970</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 29 Jun 2018 21:45:08 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Develops Inn</title><link>https://investorshangout.com/post/view?id=5109573</link><guid>https://investorshangout.com/post/view?id=5109573</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 28 Jun 2018 22:24:41 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Targets Debilitating Disorders w</title><link>https://investorshangout.com/post/view?id=5104676</link><guid>https://investorshangout.com/post/view?id=5104676</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 25 Jun 2018 23:03:09 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Takes Aim at</title><link>https://investorshangout.com/post/view?id=5100267</link><guid>https://investorshangout.com/post/view?id=5100267</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 21 Jun 2018 20:42:18 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Positioned i</title><link>https://investorshangout.com/post/view?id=5091332</link><guid>https://investorshangout.com/post/view?id=5091332</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 15 Jun 2018 20:31:32 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Extends Share Warrants Expiry am</title><link>https://investorshangout.com/post/view?id=5087895</link><guid>https://investorshangout.com/post/view?id=5087895</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 13 Jun 2018 22:52:26 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Set to Capitalize on Growth of D</title><link>https://investorshangout.com/post/view?id=5083095</link><guid>https://investorshangout.com/post/view?id=5083095</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 11 Jun 2018 20:56:38 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces En</title><link>https://investorshangout.com/post/view?id=5075172</link><guid>https://investorshangout.com/post/view?id=5075172</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 05 Jun 2018 22:06:00 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Targets Mass</title><link>https://investorshangout.com/post/view?id=5071165</link><guid>https://investorshangout.com/post/view?id=5071165</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Sat, 02 Jun 2018 00:19:50 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Adding Value to Nature-Identical</title><link>https://investorshangout.com/post/view?id=5065308</link><guid>https://investorshangout.com/post/view?id=5065308</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 29 May 2018 22:50:50 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Posts Update</title><link>https://investorshangout.com/post/view?id=5057283</link><guid>https://investorshangout.com/post/view?id=5057283</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 23 May 2018 21:49:01 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Shareholders</title><link>https://investorshangout.com/post/view?id=5048712</link><guid>https://investorshangout.com/post/view?id=5048712</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 17 May 2018 22:02:29 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Ar</title><link>https://investorshangout.com/post/view?id=5042477</link><guid>https://investorshangout.com/post/view?id=5042477</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 14 May 2018 21:04:23 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Inks NDA wit</title><link>https://investorshangout.com/post/view?id=5031987</link><guid>https://investorshangout.com/post/view?id=5031987</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 07 May 2018 21:28:44 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Obtains Addi</title><link>https://investorshangout.com/post/view?id=5027934</link><guid>https://investorshangout.com/post/view?id=5027934</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 03 May 2018 23:10:38 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Conducts Can</title><link>https://investorshangout.com/post/view?id=5006851</link><guid>https://investorshangout.com/post/view?id=5006851</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 16 Apr 2018 22:44:53 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Schedules 20</title><link>https://investorshangout.com/post/view?id=4997448</link><guid>https://investorshangout.com/post/view?id=4997448</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 09 Apr 2018 20:36:29 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Continues to</title><link>https://investorshangout.com/post/view?id=4993952</link><guid>https://investorshangout.com/post/view?id=4993952</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 05 Apr 2018 21:10:19 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Ar</title><link>https://investorshangout.com/post/view?id=4986799</link><guid>https://investorshangout.com/post/view?id=4986799</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 29 Mar 2018 21:31:08 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Technology M</title><link>https://investorshangout.com/post/view?id=4980391</link><guid>https://investorshangout.com/post/view?id=4980391</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 23 Mar 2018 21:16:41 GMT</pubDate></item><item><title>NetworkNewsWire: PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Details Cannabis Exportation Agr</title><link>https://investorshangout.com/post/view?id=4973967</link><guid>https://investorshangout.com/post/view?id=4973967</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 19 Mar 2018 21:13:23 GMT</pubDate></item></channel></rss>